Meridian Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.54M Buy
11,332
+70
+0.6% +$17.4K 0.63% 42
2025
Q4
$2.71M Buy
11,262
+2,041
+22% +$522K 0.67% 37
2025
Q3
$2.52M Buy
+9,221
New +$2.52M 0.68% 38

Other funds holding RMD

Meridian Management's RMD Position: Q1 2026 in Review

Meridian Management increased its ResMed (RMD) stake by 0.62% in Q1 2026, buying an estimated $17.4K and bringing the position to 11,332 shares worth $2.54M. The position accounts for 0.63% of the portfolio, ranked #42.

Meridian Management first reported a position in RMD in Q3 2025 and has held it in 3 quarters since. The position peaked at $2.71M in Q4 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Meridian Management held 11,332 shares of ResMed worth $2.54M as of Q1 2026.
  • Meridian Management bought 70 ResMed shares in Q1 2026, an estimated $17.4K.
  • ResMed made up 0.63% of Meridian Management's portfolio in Q1 2026, its #42 holding.
  • Meridian Management first reported a position in ResMed in Q3 2025 and has held it in 3 quarters since.
  • Meridian Management's ResMed position peaked at $2.71M in Q4 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Meridian Management's 13F filing for Q1 2026, filed 5 May 2026.